Epstein-Barr Virus-Associated Primary Central Nervous System Lymphoma in the Japanese Population

被引:21
作者
Kitai, Ryuhei [1 ]
Matsuda, Ken [1 ]
Adachi, Erika [1 ]
Saito, Yasushi [1 ]
Nakajima, Tsuyoshi [1 ]
Takeuchi, Hiroaki [1 ]
Sato, Kazufumi [1 ]
Imamura, Yoshiaki [2 ]
Kubota, Toshihiko [1 ]
机构
[1] Univ Fukui, Fac Med Sci, Dept Neurosurg, Eiheiji, Fukui 9101193, Japan
[2] Univ Fukui Hosp, Div Surg Pathol, Fukui, Japan
关键词
Epstein-Barr virus; Japan; immunocompromised patient; primary central nervous system lymphoma; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; NON-HODGKINS-LYMPHOMA; BRAIN LYMPHOMA; EBV INFECTION; IMMUNOCOMPETENT; HYBRIDIZATION; CHEMOTHERAPY; INDIVIDUALS; CARCINOMAS; EXPRESSION;
D O I
10.2176/nmc.50.114
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The incidence of Epstein-Barr virus (EBV)-associated primary central nervous system (CNS) lymphoma in Japan was assessed using in situ hybridization of EBV-encoded small ribonucleic acid-1 (EBER-1) to identify the presence of EBV in 22 cases of formalin-fixed and paraffin-embedded primary CNS lymphoma. All cases were B-cell lymphoma. EBER-1 expression was observed in the nuclei of 3 of 22 primary CNS lymphoma cases (13.6%). The incidence of EBV-positive lymphoma in Japanese cases is higher than previously reported from Western countries. Patients with EBV-positive primary CNS lymphoma showed shorter survival than those with negative tumors (median 4 months vs. 26 months). EBER-1 in situ hybridization for the detection of EBV infection is rapid and reliable. Infrequent association suggests a different pathogenetic mechanism in the evolution of these tumors. Geographical differences in the incidence of EBV-associated primary CNS lymphoma may reflect epidemiological factors.
引用
收藏
页码:114 / 118
页数:5
相关论文
共 34 条
[1]   Epstein-Barr virus associated lymphoproliferations in the AIDS setting [J].
Ambinder, RF .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (10) :1209-1216
[2]   DETECTION OF EPSTEIN-BARR VIRUS IN CNS LYMPHOMAS BY INSITU HYBRIDIZATION [J].
BASHIR, RM ;
HARRIS, NL ;
HOCHBERG, FH ;
SINGER, RM .
NEUROLOGY, 1989, 39 (06) :813-817
[3]  
BLAY JY, 1995, BLOOD, V86, P2922
[4]   Primary central nervous system lymphomas in 72 immunocompetent patients pathologic findings and clinical correlations [J].
Camilleri-Broet, S ;
Martin, A ;
Moreau, A ;
Angonin, R ;
Hénin, D ;
Gontier, MF ;
Rousselet, MC ;
Caulet-Maugendre, S ;
Cuillière, P ;
Lefrancq, T ;
Mokhtari, K ;
Morcos, M ;
Broët, P ;
Kujas, N ;
Hauw, JJ ;
Desablens, B ;
Raphaël, M .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1998, 110 (05) :607-612
[5]  
Chang K L, 1992, Diagn Mol Pathol, V1, P246, DOI 10.1097/00019606-199212000-00005
[6]  
CHANG KL, 1993, MODERN PATHOL, V6, P427
[7]  
Corn BW, 1997, CANCER, V79, P2409
[8]   Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome [J].
Cote, TR ;
Manns, A ;
Hardy, CR ;
Yellin, FJ ;
Hartge, P ;
Lemp, G ;
West, D ;
Singleton, J ;
Young, J ;
Kerndt, P ;
Deapen, D ;
Ginzberg, M ;
AntonCulver, H ;
Lieb, S ;
Hopkins, R ;
Williams, B ;
Liff, J ;
Morgan, D ;
Parkin, W .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (10) :675-679
[9]  
ElenitobaJohnson KSJ, 1997, SEMIN DIAGN PATHOL, V14, P35
[10]   EPSTEIN-BARR-VIRUS (EBV) INFECTION AND UNDIFFERENTIATED CARCINOMA OF THE PAROTID-GLAND IN CAUCASIAN PATIENTS [J].
GALLO, O ;
SANTUCCI, M ;
CALZOLARI, A ;
STORCHI, OF .
ACTA OTO-LARYNGOLOGICA, 1994, 114 (05) :572-575